ResMed Inc (RMD)
243.60
+2.05
(+0.85%)
USD |
NYSE |
Nov 21, 16:00
244.95
+1.35
(+0.55%)
After-Hours: 20:00
ResMed Gross Profit Margin (Quarterly): 58.57% for Sept. 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 58.57% |
June 30, 2024 | 58.50% |
March 31, 2024 | 57.88% |
December 31, 2023 | 55.64% |
September 30, 2023 | 54.44% |
June 30, 2023 | 55.02% |
March 31, 2023 | 55.31% |
December 31, 2022 | 56.08% |
September 30, 2022 | 56.91% |
June 30, 2022 | 57.12% |
March 31, 2022 | 56.82% |
December 31, 2021 | 56.36% |
September 30, 2021 | 56.00% |
June 30, 2021 | 56.01% |
March 31, 2021 | 58.18% |
December 31, 2020 | 57.81% |
September 30, 2020 | 58.34% |
June 30, 2020 | 58.33% |
March 31, 2020 | 58.44% |
December 31, 2019 | 58.02% |
September 30, 2019 | 57.50% |
June 30, 2019 | 57.09% |
March 31, 2019 | 57.53% |
December 31, 2018 | 57.52% |
September 30, 2018 | 58.32% |
Date | Value |
---|---|
June 30, 2018 | 53.75% |
March 31, 2018 | 58.19% |
December 31, 2017 | 58.18% |
September 30, 2017 | 58.36% |
June 30, 2017 | 52.87% |
March 31, 2017 | 58.29% |
December 31, 2016 | 58.27% |
September 30, 2016 | 57.83% |
June 30, 2016 | 58.13% |
March 31, 2016 | 57.26% |
December 31, 2015 | 58.63% |
September 30, 2015 | 57.97% |
June 30, 2015 | 57.26% |
March 31, 2015 | 59.51% |
December 31, 2014 | 62.23% |
September 30, 2014 | 62.39% |
June 30, 2014 | 62.92% |
March 31, 2014 | 63.30% |
December 31, 2013 | 64.72% |
September 30, 2013 | 63.74% |
June 30, 2013 | 62.67% |
March 31, 2013 | 62.42% |
December 31, 2012 | 61.80% |
September 30, 2012 | 61.42% |
June 30, 2012 | 60.89% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
54.44%
Minimum
Sep 2023
58.57%
Maximum
Sep 2024
56.99%
Average
57.02%
Median
Gross Profit Margin (Quarterly) Benchmarks
Boston Scientific Corp | 68.83% |
Globus Medical Inc | 56.77% |
Abbott Laboratories | 55.83% |
Haemonetics Corp | 54.25% |
Becton Dickinson & Co | 46.26% |
Gross Profit Margin (Quarterly) Related Metrics
Return on Equity | 23.76% |
Return on Assets | 16.10% |
Return on Invested Capital | 19.59% |
Profit Margin (Quarterly) | 25.43% |
Operating Margin (Quarterly) | 31.63% |
Return on Net Operating Assets | 18.51% |